Endometriosis Involving the Bladder: A Contemporary Clinicopathologic Analysis of 88 Patients
Thi T A Nguyen1, Adeboye O Osunkoya1,2,3,4
1Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA.
Abstract:
Predominantly, case reports and small case series of endometriosis involving the bladder have been published. This study aimed to provide a contemporary clinicopathologic analysis of a large cohort of patients at a major academic center in the United States. A search was made through our urologic pathology database and expert consults of the senior author for patients with bladder endometriosis from 2006 to 2024. Eighty-eight patients were included. The mean age was 37 years (range: 18-80 years). Presenting symptoms included pelvic pain, abnormal uterine bleeding, dysmenorrhea, infertility, hydronephrosis, hematuria, bladder mass, pelvic mass, or an incidental finding during workup for other diseases. The bladder serosa was the most common site of involvement: 72 (82%) patients, followed by muscularis propria: 12 (14%) patients; perivesical adipose tissue: 11 (13%) patients, and submucosa: 1 (<1%) patient. Although none had malignant transformation, a subset presented as mimickers of bladder neoplasia. Fifty-six (62%) patients had involvement of other organs/sites, most commonly the ovary: 22 (25%); large intestine: 20 (23%); uterine serosa: 18 (20%); cul-de-sac: 15 (17%); broad ligament: 6 (7%), and other pelvis/abdominal cavity sites. CD10 was utilized in 9 (10%) patients. The mean duration of follow-up was 40 months (range: 1-208 months). All patients were alive at follow-up, with 30 (34%) having residual or recurrent endometriosis requiring additional treatment. This is one of the largest clinicopathologic studies to date of bladder endometriosis, and it may present as a mimicker of benign or malignant bladder neoplasia and frequently involves other sites.
More Related Videos
08:07Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
Published on: April 5, 2024
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
Related Concept Videos
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urologic Endoscopic Procedure: Cystoscopic Examination
Urinary Tract Infection II: Pathophysiology
Anatomy of the Genitourinary System II: Bladder and Urethra
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
